AntineoplasticsLack of efficacy and various toxicities following off-label use: 26 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1950卷 / 1期

关键词：

D O I：

10.1007/s40278-023-36444-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：47 / 47

相关论文

共 50 条

[1] AntineoplasticsLack of efficacy, off-label use and various toxicities: case report
[J]. Reactions Weekly, 2023, 1967 (1) : 47 - 47
[2] AntineoplasticsLack of efficacy and off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1920 (1) : 58 - 58
[3] Bevacizumab/temozolomideLack of efficacy and various toxicities following off-label use: 2 case reports
[J]. Reactions Weekly, 2021, 1849 (1) : 93 - 93
[4] AntineoplasticsLack of efficacy, various toxicities and off label use: case report
[J]. Reactions Weekly, 2021, 1854 (1) : 47 - 47
[5] AntineoplasticsLack of efficacy followed by off-label use: 2 case reports
[J]. Reactions Weekly, 2023, 1956 (1) : 64 - 64
[6] Multiple drugsLack of efficacy, off-label use and various toxicities: 2 case reports
[J]. Reactions Weekly, 2021, 1857 (1) : 234 - 235
[7] Multiple drugsLack of efficacy, off-label use and various toxicities: 5 case reports
[J]. Reactions Weekly, 2023, 1953 (1) : 276 - 276
[8] BosutinibVarious toxicities and lack of efficacy following off-label use: 5 case reports
[J]. Reactions Weekly, 2022, 1918 (1) : 111 - 111
[9] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1866 (1) : 47 - 47
[10] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1857 (1) : 44 - 44

← 1 2 3 4 5 →